Saccharomyces boulardii, 400
Saddle nose deformity, physical findings
diagnostic features, 53
noninfectious mimics, 53
Salmonella, 352
Salmonellaspp., 330
Salmonella typhi, 330
Salves antibiotics, 360
Sarcoidosis, 138
SARS.SeeSevere acute respiratory syndrome (SARS)
SARS-associated coronavirus, 474–475
SBE.SeeSubacute bacterial endocarditis (SBE)
SBP.SeeSpontaneous bacterial peritonitis (SBP)
Scalp folliculitis, in burn patients, 372
Scarlet fever, 35
SCCmec.SeeStaphylococcal cassette chromosome
mec (SCCmec)
Scedosporium prolificans, 395
Scedosporiumspp.
infection, in SOT recipients, 395
Schistosomiasis, 331, 402
SCID.SeeSevere combined immunodeficiency
syndrome (SCID)
Scrotal, physical findings
diagnostic features, 61
noninfectious mimics, 61
PE findings, 61
Scrotal purpura, physical findings
diagnostic features, 60
noninfectious mimics, 60
SDD.SeeSelective decontamination of digestive
tract (SDD)
Secondary syphilis, 32, 71
Selective decontamination of digestive tract
(SDD), 185
Semi-quantitative (SQ) catheter tip cultures, 208
Sensorineural hearing loss, physical findings
diagnostic features, 52
noninfectious mimics, 52
Sepsis, 525
burn wound infections and, 368–369
clinical conditions associated with, 129
clinical mimics of, 130
clinical signs of, 128, 129
defined, 26
diagnostic approach, 128
empiric therapy of, 130, 131
laboratory abnormalities in, 130
mimics, 131
syndrome, mechanism of
in asplenic patients, 350–351
Sepsis-related organ failure assessment, 261
Septic emboli, 96
Septicemic plague, 477
Septic shock, 26–27
diagnosis of, 26
mortality rate, 26–27
Septic syndrome, 528
Septic thrombophlebitis, CVC infections
and, 208, 209
S. aureusABE, 210–214
Serious systemic infections, 500, 501
anti-MRSA antibiotics for, 506–507
Serotonin syndrome, 549
Serratia marcescens, 302
Serum
CRP, 147
ferritin levels, 147
PCT, 147
Serum protein electrophoresis (SPEP), 138
Serum sickness, 137
Serum transaminases, 10
Severe acute respiratory syndrome (SARS), 328,
473, 474–475
Severe combined immunodeficiency syndrome
(SCID), 378
Shigellaspp., 330
Shigellosis, 330
Shock, severe CAP with
diagnostic approach, 166
functional/anatomic hyposplenia and, 166
Silver nitrate, 362
Silver sulfadiazine, 361
Single fever spikes, 6–8
Single nucleotide polymorphisms (SNPs), 369
Sinusitis, in burn patients, 372
Skin and soft tissue infections
bites, 301–302
carbuncles, 297
cellulitis, 298–299
diagnosis of, 299
treatment, 300
chancriform lesions, anthrax, 300–301
classification of, 296–297
community-acquired methicillin-resistant
S. aureus(CA-MRSA), 315–316
diabetic foot infection, 308–309
ecthyma gangrenosum, 310
erysipelas, 297–298
treatment, 298
erysipeloid, 300
furuncles, 297
in immunocompromised host, 310
impetigo, 297
in injection drug users, 309
microbial flora, 295–296
necrotizing infections
cellulitis, 302
Fournier’s gangrene, 305
gas gangrene, 305–307
necrotizing fasciitis (NF), 302–305
nonclostridial myonecrosis, 307–308
pyomyositis, 308
surgical site infections (SSIs), 310–311
systemic syndromes
purpura fulminans, 315
staphylococcal scalded skin syndrome (SSSS),
311–312
toxic shock syndrome (TSS), 312–314
SLE.SeeSystemic lupus erythematosis (SLE);
Systemic lupus erythematosus (SLE)
Smallpox, 37–38, 476–477Index 577